Search Results - "Őrfi, Lászlȯ"

Refine Results
  1. 1

    Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy by Torka, Robert, Pénzes, Kinga, Gusenbauer, Simone, Baumann, Christine, Szabadkai, István, Őrfi, Lászlȯ, Kéri, György, Ullrich, Axel

    Published in Neoplasia (New York, N.Y.) (01-04-2014)
    “…Abstract The Axl receptor tyrosine kinase (RTK) has been established as a strong candidate for targeted therapy of cancer. However, the benefits of targeted…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells by Hodrea, Judit, Tran, Minh Ngoc, Besztercei, Balazs, Medveczki, Timea, Szabo, Attila J, Őrfi, Laszlo, Kovacs, Illes, Fekete, Andrea

    “…Primary open-angle glaucoma remains a global issue, lacking a definitive treatment. Increased intraocular pressure (IOP) is considered the primary risk factor…”
    Get full text
    Journal Article
  4. 4

    AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression by ZHANG, Yi-Xiang, KNYAZEV, Peter G, CHEBURKIN, Yuri V, SHARMA, Kirti, KNYAZEV, Yuri P, ORFI, Laszlo, SZABADKAI, Istvan, DAUB, Henrik, KERI, György, ULLRICH, Axel

    Published in Cancer research (Chicago, Ill.) (15-03-2008)
    “…Protein kinases play important roles in tumor development and progression. A variety of members of this family of signal transduction enzymes serve as targets…”
    Get full text
    Journal Article
  5. 5

    Optimization of Sirius Red-Based Microplate Assay to Investigate Collagen Production In Vitro by Szász, Csenge, Pap, Domonkos, Szebeni, Beáta, Bokrossy, Péter, Őrfi, László, Szabó, Attila J, Vannay, Ádám, Veres-Székely, Apor

    “…Tissue fibrosis is characterized by chronic fibroblast activation and consequently excessive accumulation of collagen-rich extracellular matrix. In vitro…”
    Get full text
    Journal Article
  6. 6

    Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion by Rybniker, Jan, Chen, Jeffrey M., Sala, Claudia, Hartkoorn, Ruben C., Vocat, Anthony, Benjak, Andrej, Boy-Röttger, Stefanie, Zhang, Ming, Székely, Rita, Greff, Zoltán, Őrfi, László, Szabadkai, István, Pató, János, Kéri, György, Cole, Stewart T.

    Published in Cell host & microbe (08-10-2014)
    “…Mycobacterium tuberculosis (Mtb) requires protein secretion systems like ESX-1 for intracellular survival and virulence. The major virulence determinant and…”
    Get full text
    Journal Article
  7. 7

    Integrating molecular diagnostics into anticancer drug discovery by Peták, István, Schwab, Richárd, Őrfi, László, Kopper, László, Kéri, György

    Published in Nature reviews. Drug discovery (01-07-2010)
    “…Efforts to repeat the success of pioneering molecularly targeted cancer drugs, such as trastuzumab, for particular patient populations have been hampered by…”
    Get full text
    Journal Article
  8. 8

    The role of PI3K-Akt-mTOR axis in Warburg effect and its modification by specific protein kinase inhibitors in human and rat inflammatory macrophages by Bögel, Gábor, Sváb, Gergely, Murányi, József, Szokol, Bálint, Kukor, Zoltán, Kardon, Tamás, Őrfi, László, Tretter, László, Hrabák, András

    Published in International immunopharmacology (15-11-2024)
    “…•Expression of HIF-1α, NOS2 and inflammatory cytokines increased in inflammatory macrophages.•Increased expressions of HIF-1α, NOS2 and IP-10 were reduced by…”
    Get full text
    Journal Article
  9. 9

    Transient Agarose Spot (TAS) Assay: A New Method to Investigate Cell Migration by Veres-Székely, Apor, Pap, Domonkos, Szebeni, Beáta, Őrfi, László, Szász, Csenge, Pajtók, Csenge, Lévai, Eszter, Szabó, Attila J, Vannay, Ádám

    “…Fibroblasts play a central role in diseases associated with excessive deposition of extracellular matrix (ECM), including idiopathic pulmonary fibrosis…”
    Get full text
    Journal Article
  10. 10

    A Closer Look at the Structure of Sterically Stabilized Liposomes: A Small-Angle X-ray Scattering Study by Varga, Zoltán, Berényi, Szilvia, Szokol, Bálint, Őrfi, László, Kéri, György, Peták, István, Hoell, Armin, Bóta, Attila

    Published in The journal of physical chemistry. B (27-05-2010)
    “…The evaluation of the radial electron density profile of a drug containing a sterically stabilized liposomal system is described. Using synchrotron small-angle…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Small-Molecule Inhibitors of NADPH Oxidase 4 by Borbély, Gábor, Szabadkai, István, Horváth, Zoltán, Markó, Péter, Varga, Zoltán, Breza, Nóra, Baska, Ferenc, Vántus, Tibor, Huszár, Mónika, Geiszt, Miklós, Hunyady, László, Buday, László, Őrfi, László, Kéri, György

    Published in Journal of medicinal chemistry (23-09-2010)
    “…NOX enzymes are the major contributors in many oxidative damage related diseases. Unfortunately, at present no specific NOX inhibitor is available. Here, we…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    DNA binding of sunitinib: Spectroscopic evidence via circular dichroism and nuclear magnetic resonance by Kiss, Eszter, Mirzahosseini, Arash, Hubert, Ágnes, Ambrus, Attila, Őrfi, László, Horváth, Péter

    “…•Plasmid DNA can be used in DNA-ligand binding experiments with certain considerations.•A two-step binding mechanism is proposed for sunitinib.•In the first…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Targeted drug combination therapy design based on driver genes by Zsákai, Lilian, Sipos, Anna, Dobos, Judit, Erős, Dániel, Szántai-Kis, Csaba, Bánhegyi, Péter, Pató, János, Őrfi, László, Matula, Zsolt, Mikala, Gábor, Kéri, György, Peták, István, Vályi-Nagy, István

    Published in Oncotarget (03-09-2019)
    “…Targeted therapies against cancer types with more than one driver gene hold bright but elusive promise, since approved drugs are not available for all driver…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Leads for antitubercular compounds from kinase inhibitor library screens by Magnet, Sophie, Hartkoorn, Ruben C, Székely, Rita, Pató, János, Triccas, James A, Schneider, Patricia, Szántai-Kis, Csaba, Őrfi, László, Chambon, Marc, Banfi, Damiano, Bueno, Manuel, Turcatti, Gerardo, Kéri, György, Cole, Stewart T

    Published in Tuberculosis (Edinburgh, Scotland) (01-11-2010)
    “…Summary Discovering new drugs to treat tuberculosis more efficiently and to overcome multidrug resistance is a world health priority. To find antimycobacterial…”
    Get full text
    Journal Article
  20. 20

    Chemoenzymatic route to Tyrphostins involving lipase-catalyzed kinetic resolution of 1-phenylethanamine with alkyl cyanoacetates as novel acylating agents by Csuka, Pál, Boros, Zoltán, Őrfi, László, Dobos, Judit, Poppe, László, Hornyánszky, Gábor

    Published in Tetrahedron: asymmetry (15-07-2015)
    “…[Display omitted] Ethyl and isopropyl cyanoacetates were tested as acylating agents in the kinetic resolution of racemic 1-phenylethanamine rac-1 catalyzed by…”
    Get full text
    Journal Article